Endogenous 4-1BB Ligand Plays a Critical Role in Protection from Influenza-induced Disease
Overview
Affiliations
A critical issue during severe respiratory infection is whether it is the virus or the host response that does the most damage. In this study, we show that endogenous 4-1BBL plays a critical role in protecting mice from severe effects of influenza disease. During mild respiratory influenza infection in which virus is rapidly cleared, the inducible costimulatory receptor 4-1BB is only transiently induced on lung T cells and 4-1BB ligand (4-1BBL) is completely dispensable for the initial CD8 T cell response and mouse survival. In contrast, during more severe respiratory influenza infection with prolonged viral load, 4-1BB expression on lung CD8 T cells is sustained, and 4-1BBL-deficient mice show decreased CD8 T cell accumulation in the lungs, decreased viral clearance, impaired lung function, and increased mortality. Transfer of an optimal number of naive Ag-specific T cells before infection protects wild-type but not 4-1BBL-deficient mice from an otherwise lethal dose of influenza virus. Transfer of T cells lacking the proapoptotic molecule Bim extends the lifespan of 4-1BBL-deficient mice by one to three days, suggesting that at least part of the role of 4-1BB/4-1BBL is to prolong effector cell survival long enough to clear virus. Intranasal delivery of 4-1BBL by recombinant adenovirus marginally improves survival of 4-1BBL-deficient mice at low dose, but exacerbates disease at high dose. These findings suggest a rationale for the evolutionary accumulation of inducible costimulatory molecules, thereby allowing the immune system to sustain the expression of molecules such as 4-1BB to a level commensurate with severity of infection.
4-1BB immunotherapy: advances and hurdles.
Singh R, Kim Y, Lee S, Eom H, Choi B Exp Mol Med. 2024; 56(1):32-39.
PMID: 38172595 PMC: 10834507. DOI: 10.1038/s12276-023-01136-4.
Yin X, Baugnon N, Krishnan R, Potter C, Yarlagadda S, Keadle T J Gen Virol. 2022; 103(6).
PMID: 35766977 PMC: 10027025. DOI: 10.1099/jgv.0.001756.
Zhan M, Gao X, Wang C, Peng F, Wang X, Xu H World J Clin Cases. 2021; 9(7):1619-1630.
PMID: 33728305 PMC: 7942032. DOI: 10.12998/wjcc.v9.i7.1619.
The Murine CD137/CD137 Ligand Signalosome: A Signal Platform Generating Signal Complexity.
Choi B, Lee H Front Immunol. 2020; 11:553715.
PMID: 33362756 PMC: 7758191. DOI: 10.3389/fimmu.2020.553715.
CD137 costimulation enhances the antiviral activity of Vγ9Vδ2-T cells against influenza virus.
Pei Y, Wen K, Xiang Z, Huang C, Wang X, Mu X Signal Transduct Target Ther. 2020; 5(1):74.
PMID: 32488072 PMC: 7266814. DOI: 10.1038/s41392-020-0174-2.